ARCHIVES

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

This article is from The Cancer Letter archive.

Vol. 03 No. 10 | March 11, 1977

Download PDF Visit The Full Archive

Related Articles

FDA Ceases Exclusion Of Women From Early Drug Studies

May 7, 1993

Bush Names Leffall Cancer Panel Chairman, Appoints Cyclist Armstrong To Panel

May 31, 2002

Low-Dose Aspirin Cuts Risk Of Colorectal Growths

April 26, 2002

Improvements Still Needed To Reduce Chemo Errors

November 25, 2005

ACCC Preliminary Report on DRGs Finds Case Mix Can Alter Profit/ Loss Pictures

March 29, 1985

New CREG Cell Kinetics Study Axed By DCTBSC

March 31, 1978